Chimeric Antigen Receptor Immunotherapies Show Promise for Viral Targets, But Data Remain Limited
Chimeric antigen receptor (CAR) T-cell therapies, long successful in oncology, are now being adapted to target chronic viral infections like hepatitis B (HBV) and HIV, offering a potential path toward ... Read More